Protocol Writing, Review, IRB submission for: A Phase I/II Trial in Patients with Metastatic Gastrointestinal Epithelial Cancer Administering Tumor-Infiltrating Lymphocytes in which the Gene Encoding CISH was Inactivated Using the CRISPR/ Cas9 System

Project: Research project

Description

Protocol Writing, Review, IRB submission for: A Phase I/II Trial in Patients with Metastatic Gastrointestinal Epithelial Cancer Administering Tumor-Infiltrating Lymphocytes in which the Gene Encoding CISH was Inactivated Using the CRISPR/ Cas9 System
StatusFinished
Effective start/end date2/1/191/1/20

Funding

  • INTIMA CAPITAL, LLC

Fingerprint

Clustered Regularly Interspaced Short Palindromic Repeats
Tumor-Infiltrating Lymphocytes
Gastrointestinal Neoplasms
Research Ethics Committees
Genes